CLINICO-RADIOLOGICAL PROFILE IN COVID-19 PATIENTS AND ITS CORRELATION TO PRIOR BCG VACCINATIONS STATUS
Main Article Content
Keywords
COVID-19, BCG vaccination, mortality, severity, radiological profile
Abstract
Background: Given the impact of COVID-19 and the global scramble to find ways to combat its spread and mortality, there has been interest in whether existing vaccines like BCG could provide some protection against the virus.
Aim: This study aims to investigate the effectiveness of prior BCG vaccination in reducing COVID-19 infection and severity.
Methods: The study included adult patients, aged 18 years or older with laboratory confirmed COVID 19 either by Rapid antigen test(RAT) or RNA reverse transcriptase polymerase chain reaction (RT-PCR) assay from nasal, pharyngeal or lower respiratory tract sample, who were admitted for either quarantine or required hospitalization in view of moderate to severe COVID 19 disease. Radiological disease severity was assessed based on CT findings and severity score. These clinical, radiological and inflammatory parameters were compared between BCG vaccinated and non vaccinated patients.
Results: A total of 918 patients with laboratory confirmed COVID-19 infection of varying severity were included. Out of 918 included patients 604 (65.8%) were males and 314 (34.2%) were females with male to female ratio of 1.8:1. Mean age of study population was 51.5±17.1 years with age ranging from 18 to 100 years. Total 472 patients ( 51.4%) had evidence of prior BCG vaccination whereas 446 patients (48.6 %) had no evidence of prior BCG vaccination. Majority of patients had severe COVID illness ( 434, 47.3%) followed by mild ( 286, 31.1%) and moderate illness ( 198, 21.6%). Most common comorbidity was diabetes ( 311, 33.9%) followed by hypertension ( 295, 32.1%).
Conclusion: We concluded that neonatal BCG vaccination limits the radiological severity of the COVID-19 pneumonia but does not give any mortality benefit to COVID-19 patients.
References
2. World Health Organization . Geneva (Switzerland): World Health Organization; 2020. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020.
3. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID- 19) implicate special control measures. J Med Virol. 2020 Mar 5
4. Fauci AS, Lane HC, Redfield RR. Covid-19—navigating the uncharted. N Engl J Med. 2020;382:1268–1269. doi: 10.1056/NEJMe2002387
5. Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M. Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125:479–481. doi: 10.1016/j.anai.2020.07.012
6. Gursel M, Gursel I. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Allergy. (2020) 75:1815–9.
7. Kantor IN. BCG Versus COVID-19? Medicina (2020) 80:292–4.
8. Pereira, S.M., Barreto, F.R., de Souza, R.A. et al. Previous BCG vaccination is associated with less severe clinical progression of COVID-19. BMC Med 21, 145 (2023).
9. World Health Organization (February 2018). "BCG vaccines: WHO position paper – February 2018". Weekly Epidemiological Record. 93 (8): 73–96.
10. N.E. Aronson, M. Santosham, G.W. Comstock, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study.
11. Andersen P Doherty TMThe success and failure of BCG—implications for a novel tuberculosis vaccine, Nat Rev Microbiol, 2005, vol. 3 (pg. 656-62).
12. Netea, M.G., Quintin, J., van der Meer, J.W.M. (2011). Trained immunity: A memory for innate host defense. Cell Host & Microbe, 9(5), 355-361.
13. Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, et al. Safety and Efficacy of BCG Re-Vaccination in Relation to COVID-19 Morbidity in Healthcare Workers: A Double-Blind, Randomised, Controlled, Phase 3 Trial. EClinicalMedicine (2022) 48:101414. doi: 10.1016/j.eclinm.2022.101414
14. Harris E. BCG Vaccine Not Effective Against COVID-19. JAMA. 2023;329(20):1730
15. Pan F, Ye T, Sun P et al (2020) Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology 200370. 10.1148/radiol.2020200370
16. Updated Detailed Clinical Management Protocol for COVID19 Adults. Ministry of Health and Family Welfare. India. https://www.mohfw.gov.in.
17. Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.
18. Ong CWM, Migliori GB, Raviglione M, et al. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: a consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J 2020;56:2001727.
19. Aaby P, Roth A, Ravn H, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011; 204:245-52. 15
20. Biering-Sorensen S, Aaby P, Lund N, et al. Early BCGDenmark and neonatal mortality among infants weighing<2500 g: a randamoised controlled trial.
21. Hollm-Delgado MG, Stuart EA, Black RE. Acute lower respiratory infection among Bacille Calmette-Guerin (BCG)-vaccinated children. Pediatrics. 2014;133(1):e73-81.
22. Tavares Cruz C, Almeida B, Troster E, Oliveira C. Systematic Review of the Non-Specific Effects of Bacillus Calmette-Guérin Vaccine on Child Mortality. Journal of Infectious Diseases and Treatment. 2017;03(02)
23. Kleinnijenhuis, J., Quintin, J., Preijers, F., Benn, C. S., Joosten, L. A., Jacobs, C., ... & Netea, M. G. (2014). Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. Journal of Innate Immunity, 6(2), 152-158. https://doi.org/10.1159/000355628
24. Khanum I, Kumar L, Awan S, Jamil B. Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population. Clin Exp Vaccine Res. 2021 Sep;10 (3):276-281. doi: 10.7774/cevr.2021.10.3.276. Epub 2021 Sep 30. PMID: 34703811; PMCID: PMC8511583
25. Richardson S, Hirsch JS, Narasimhan M, et al; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323 (20):2052-2059.
26. Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, Diao K, Lin B, Zhu X, Li K, Li S, Shan H, Jacobi A, Chung M. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020 Jun;295(3):200463. doi:10.1148/radiol.2020200463. Epub 2020 Feb 20. PMID: 32077789; PMCID: PMC7233369
27. Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. J Am Coll Radiol. 2020 Jun;17(6):701-709. doi: 10.1016/j.jacr.2020.03.006. Epub 2020 Mar 25. PMID: 32283052; PMCID: PMC7151282
28. Fu F, Lou J, Xi D, Bai Y, Ma G, Zhao B, Liu D, Bao G, Lei Z, Wang M. Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia. Eur Radiol. 2020 Oct;30(10):5489-5498. doi: 10.1007/s00330-020-06920-8. Epub 2020 May 20. PMID: 32435925; PMCID: PMC7237879.
29. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 2020;(Jan).